The Quantellect read.As of Nov 19, 2026, 5 active firms cover Harrow Health Inc: 5 rate it Buy or better, 0 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets span $45.00 to $88.00, a moderate spread. The average target of $65.33 sits 103% above the current $32.17. The rating mix has stayed broadly stable, with Buy-side ratings easing from 7 to 5 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.14 next quarter toward $1.87 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 active firms
Buy
Strong Buy00%
Buy5100%
Neutral00%
Sell00%
Strong Sell00%
Based on 5 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$65.33
+103.1% upside
Average target across 3 active firms as of Nov 19, 2026 vs $32.17 current
Highest Target$88.00
Average Target$65.33
Lowest Target$45.00
Detailed analyst forecasts for HROW
Showing 1–3 of 3 named analysts shown · 5 active firms in the rating projection
As of Nov 19, 2026, 5 of 5 active firms rate HROW a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
HROW EPS & revenue forecast
EPS · NEXT QUARTER
$-0.14
Range $-0.51 – $0.22 · 2 analysts · -80% YoY
Next period, 2 analysts expect Harrow Health Inc to earn $-0.14 a share (range $-0.51 – $0.22), versus $-0.74 a year earlier. Full-year consensus is $-0.02, growing to $1.87 the year after.
REVENUE · NEXT QUARTER
$92.7M
Range $84.4M – $104.6M · 2 analysts · +110% YoY
Revenue is expected to reach $92.7M (range $84.4M – $104.6M), +109.8% year-over-year. Full-year consensus is $350.7M, rising to $524.0M next year.
Top analysts covering Harrow Health Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on HROW.
#1
Chase Knickerbocker
Craig-Hallum · Rank #17
Buy
$59.00+83.4% to target
Overall win rate
61%
+ Follow
#2
Mayank Mamtani
B. Riley Securities · Rank #36
Buy
$60.00+86.5% to target
Overall win rate
49%
+ Follow
#3
TF
Thomas Flaten
Lake Street · Rank #306
Buy
$60.00+86.5% to target
Overall win rate
40%
+ Follow
#4
Yi Chen
HC Wainwright & Co. · Rank #350
Buy
$70.00+117.6% to target
Overall win rate
34%
+ Follow
#5
Thomas Shrader
BTIG · Rank #553
Buy
$63.00+95.8% to target
Overall win rate
32%
+ Follow
HROW stock forecast FAQ
What is HROW's average 12-month price target?+
The 3 active firms with a live target average $65.33 for Harrow Health Inc over the next 12 months, ranging from a $88.00 high to a $45.00 low, as of Nov 19, 2026.
Is HROW stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 5 active firms as of Nov 19, 2026, 5 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for HROW?+
The Street-high target is $88.00 (Cantor Fitzgerald), and the Street-low is $45.00 (Leerink Partners). The average of all 3 active-firm targets is $65.33.
How many active Wall Street firms cover HROW?+
5 active firms have a recognized rating on Harrow Health Inc as of Nov 19, 2026, and 3 active firms carry a live 12-month price target.
Who is the most accurate analyst covering HROW?+
Among analysts who currently cover HROW, Chase Knickerbocker of Craig-Hallum has the strongest overall Quantellect track record (Rank #17). Their current call is Buy with a $59.00 target.
What is Harrow Health Inc's projected EPS for next quarter?+
The consensus estimate is $-0.14 per share (range $-0.51 – $0.22) across 2 analysts. Full-year EPS is projected at $-0.02, rising to $1.87 the following year.
How much revenue is Harrow Health Inc expected to report next quarter?+
Consensus revenue is $92.7M (range $84.4M – $104.6M). Full-year revenue is projected at $350.7M, growing to $524.0M next year.
Have analysts been upgrading or downgrading HROW lately?+
As of Nov 19, 2026, 5 of 5 active firms rate HROW a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their HROW calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.